Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin

<p>Supplementary tables</p>

Збережено в:

Бібліографічні деталі
Автор:	Gwo Yaw Ho (14961416) (author)
Інші автори:	Elizabeth L. Kyran (14961419) (author), Justin Bedo (14961422) (author), Matthew J. Wakefield (14952747) (author), Darren P. Ennis (14961425) (author), Hasan B. Mirza (14961428) (author), Cassandra J. Vandenberg (14961431) (author), Elizabeth Lieschke (14961434) (author), Andrew Farrell (14961437) (author), Anthony Hadla (14961440) (author), Ratana Lim (14961443) (author), Genevieve Dall (14961446) (author), James E. Vince (14961449) (author), Ngee Kiat Chua (14961452) (author), Olga Kondrashova (14952696) (author), Rosanna Upstill-Goddard (14961455) (author), Ulla-Maja Bailey (14961458) (author), Suzanne Dowson (14961461) (author), Patricia Roxburgh (14961464) (author), Rosalind M. Glasspool (14961467) (author), Gareth Bryson (14961470) (author), Andrew V. Biankin (14937726) (author), Susanna L. Cooke (9957193) (author), Gayanie Ratnayake (14961473) (author), Orla McNally (14961476) (author), Nadia Traficante (14961479) (author), Anna DeFazio (14952738) (author), S. John Weroha (14961482) (author), David D. Bowtell (14961485) (author), Iain A. McNeish (14932661) (author), Anthony T. Papenfuss (10025621) (author), Clare L. Scott (14952750) (author), Holly E. Barker (14946729) (author)
Опубліковано:	2025
Предмети:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Mechanisms Cellular responses to anticancer drugs Genome Biology Gynecological Cancers Ovarian cancer Metabolism Metabolic pathways Preclinical Models Xenograft models Rare Cancers Translational Research
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
за авторством: Evangeline R. Jackson (15558808)
Опубліковано: (2025)

Supplementary Data S1 from A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States
за авторством: Namhee Kim (14963603)
Опубліковано: (2025)

Supplementary Data S2 from A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States
за авторством: Namhee Kim (14963603)
Опубліковано: (2025)

Supplementary Data from Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer
за авторством: Lixuan Wei (14962431)
Опубліковано: (2025)

Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
за авторством: Nicole A. Traphagen (16677391)
Опубліковано: (2025)

Supplementary Table S2 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
за авторством: Nicole A. Traphagen (16677391)
Опубліковано: (2025)

Supplementary Table S2 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
за авторством: Pochung Jordan Chou (14851578)
Опубліковано: (2025)

Supplementary Table S3 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
за авторством: Pochung Jordan Chou (14851578)
Опубліковано: (2025)

Supplementary Table S4 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
за авторством: Pochung Jordan Chou (14851578)
Опубліковано: (2025)

Supplementary Movie S1 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
за авторством: Fang Wei (15057172)
Опубліковано: (2025)

Supplementary Movie S2 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
за авторством: Fang Wei (15057172)
Опубліковано: (2025)

Supplementary Movie S3 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
за авторством: Fang Wei (15057172)
Опубліковано: (2025)

Supplementary Movie S4 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
за авторством: Fang Wei (15057172)
Опубліковано: (2025)

Supplementary Movie S5 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
за авторством: Fang Wei (15057172)
Опубліковано: (2025)

Supplementary Movie S6 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
за авторством: Fang Wei (15057172)
Опубліковано: (2025)

Supplementary Movie S7 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
за авторством: Fang Wei (15057172)
Опубліковано: (2025)

Supplementary Movie S8 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
за авторством: Fang Wei (15057172)
Опубліковано: (2025)

Supplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
за авторством: Jesse C. Patterson (14962862)
Опубліковано: (2025)

Supplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
за авторством: Jesse C. Patterson (14962862)
Опубліковано: (2025)

Supplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
за авторством: Jesse C. Patterson (14962862)
Опубліковано: (2025)

Supplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
за авторством: Jesse C. Patterson (14962862)
Опубліковано: (2025)

Supplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
за авторством: Jesse C. Patterson (14962862)
Опубліковано: (2025)

Supplementary Movie S6 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
за авторством: Jesse C. Patterson (14962862)
Опубліковано: (2025)

Supplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
за авторством: Jesse C. Patterson (14962862)
Опубліковано: (2025)

Supplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
за авторством: Jesse C. Patterson (14962862)
Опубліковано: (2025)

Supplementary Movie S9 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
за авторством: Jesse C. Patterson (14962862)
Опубліковано: (2025)

Supplementary Table S1 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Table S3 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Table S4 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Table S5 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Supplementary Tables from Biallelic <i>Dicer1</i> Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of <i>DICER1</i> Syndrome–Associated Cancer
за авторством: Yemin Wang (17315078)
Опубліковано: (2025)

Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
за авторством: Alyssa C. Flint (16676029)
Опубліковано: (2025)

Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
за авторством: Alyssa C. Flint (16676029)
Опубліковано: (2025)

Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
за авторством: Juliana Navarro-Yepes (17079059)
Опубліковано: (2025)

Supplementary Table S1 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
за авторством: Phyllis S.Y. Chong (17141520)
Опубліковано: (2025)

Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
за авторством: Phyllis S.Y. Chong (17141520)
Опубліковано: (2025)

Table ST1 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
за авторством: Ossia M. Eichhoff (14964145)
Опубліковано: (2025)

Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
за авторством: Ossia M. Eichhoff (14964145)
Опубліковано: (2025)

Table ST3 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
за авторством: Ossia M. Eichhoff (14964145)
Опубліковано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_3qp19bpcsrejgcekh12ie35amf